IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients. Vakrakou AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, et al. J Neuroimmunol 2021;361:577759.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vakrakou AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, et al. IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients. J Neuroimmunol 2021;361:577759.
PMID: 34742035